Percutaneous stenting for superior vena cava stenosis following surgical repair of congenital heart defects: A two case report

Georgios E. Papadopoulos , Ilias Ninios , Sotirios Evangelou , Andreas Ioannides , Vlasis Ninios
{"title":"Percutaneous stenting for superior vena cava stenosis following surgical repair of congenital heart defects: A two case report","authors":"Georgios E. Papadopoulos ,&nbsp;Ilias Ninios ,&nbsp;Sotirios Evangelou ,&nbsp;Andreas Ioannides ,&nbsp;Vlasis Ninios","doi":"10.1016/j.crmic.2025.100104","DOIUrl":null,"url":null,"abstract":"<div><div>Superior vena cava (SVC) stenosis is a rare but serious complication following surgical repair of congenital heart defects, often resulting in significant venous congestion, facial and upper extremity swelling, increased venous pressures, and impaired hemodynamics. Surgical re-intervention carries substantial risks, whereas percutaneous stenting offers a minimally invasive and effective alternative. We present two cases of symptomatic SVC stenosis following congenital heart defect repair. Both patients underwent detailed imaging with cardiac MRI and CT angiography, confirming severe SVC stenosis. Percutaneous intervention was performed using self-expanding Wallstents deployed under fluoroscopic guidance, with tailored post-dilation strategies to optimize luminal expansion. Immediate symptomatic relief was achieved in both cases, with complete resolution of venous congestion. Post-procedure anticoagulation included warfarin for six months, followed by long-term aspirin therapy. Follow-up imaging demonstrated sustained stent patency without restenosis or thrombosis. These cases highlight percutaneous stenting as a viable and effective approach for managing post-surgical SVC stenosis, offering a safe alternative to surgical re-intervention. Future research should focus on optimizing stent designs and post-procedural management strategies to further improve patient outcomes.</div></div>","PeriodicalId":100217,"journal":{"name":"Cardiovascular Revascularization Medicine: Interesting Cases","volume":"9 ","pages":"Article 100104"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine: Interesting Cases","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2950275625000504","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Superior vena cava (SVC) stenosis is a rare but serious complication following surgical repair of congenital heart defects, often resulting in significant venous congestion, facial and upper extremity swelling, increased venous pressures, and impaired hemodynamics. Surgical re-intervention carries substantial risks, whereas percutaneous stenting offers a minimally invasive and effective alternative. We present two cases of symptomatic SVC stenosis following congenital heart defect repair. Both patients underwent detailed imaging with cardiac MRI and CT angiography, confirming severe SVC stenosis. Percutaneous intervention was performed using self-expanding Wallstents deployed under fluoroscopic guidance, with tailored post-dilation strategies to optimize luminal expansion. Immediate symptomatic relief was achieved in both cases, with complete resolution of venous congestion. Post-procedure anticoagulation included warfarin for six months, followed by long-term aspirin therapy. Follow-up imaging demonstrated sustained stent patency without restenosis or thrombosis. These cases highlight percutaneous stenting as a viable and effective approach for managing post-surgical SVC stenosis, offering a safe alternative to surgical re-intervention. Future research should focus on optimizing stent designs and post-procedural management strategies to further improve patient outcomes.
先天性心脏缺损手术修复后经皮上腔静脉狭窄置入术:附2例报告
上腔静脉(SVC)狭窄是先天性心脏缺损手术修复后一种罕见但严重的并发症,通常导致明显的静脉充血,面部和上肢肿胀,静脉压升高和血流动力学受损。手术再干预具有很大的风险,而经皮支架置入术提供了一种微创和有效的替代方法。我们报告两例先天性心脏缺损修复后出现症状性上腔静脉狭窄的病例。两例患者均行心脏MRI和CT血管造影,证实严重的SVC狭窄。经皮介入治疗在透视引导下使用自扩张的wallstent,并采用量身定制的扩张后策略来优化腔内扩张。两例患者均获得即时症状缓解,静脉充血完全消除。术后抗凝治疗包括6个月的华法林,随后是长期阿司匹林治疗。随访影像显示支架持续通畅,无再狭窄或血栓形成。这些病例强调了经皮支架置入术作为治疗术后SVC狭窄的可行和有效的方法,为手术再干预提供了一种安全的选择。未来的研究应侧重于优化支架设计和术后管理策略,以进一步改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信